MedPath

University of Oxford

University of Oxford logo
🇬🇧United Kingdom
Ownership
Private
Established
1096-01-01
Employees
10K
Market Cap
-
Website
http://www.ox.ac.uk

A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21

Phase 1
Active, not recruiting
Conditions
Malaria, Plasmodium Falciparum
Interventions
Biological: Matrix-M with RH5.2 VLP and/or R21
First Posted Date
2022-05-03
Last Posted Date
2025-03-28
Lead Sponsor
University of Oxford
Target Recruit Count
107
Registration Number
NCT05357560
Locations
🇬🇲

Medical Research Council Unit, Fajara, Banjul, Gambia

The HIFUB Study (HIFU in Breast Cancer)

Not Applicable
Conditions
Breast Cancer
Interventions
Device: High Intensity Focused Ultrasound (HIFU) to the Breast Cancer
First Posted Date
2022-04-27
Last Posted Date
2022-04-27
Lead Sponsor
University of Oxford
Target Recruit Count
15
Registration Number
NCT05350059

Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma

Phase 2
Recruiting
Conditions
Melanoma (Skin)
Melanoma, Uveal
Interventions
First Posted Date
2022-04-07
Last Posted Date
2025-02-10
Lead Sponsor
University of Oxford
Target Recruit Count
850
Registration Number
NCT05315258
Locations
🇬🇧

Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom

🇬🇧

The Clatterbridge Cancer Centre, Liverpool, United Kingdom

🇬🇧

The Christie Hospital, Manchester, United Kingdom

and more 7 locations

A Study in Tanzania of a New Vaccine Against Two Types of Ebola

Phase 1
Active, not recruiting
Conditions
Ebola
Interventions
Biological: ChAdOx1 biEBOV
First Posted Date
2022-03-29
Last Posted Date
2023-02-08
Lead Sponsor
University of Oxford
Target Recruit Count
76
Registration Number
NCT05301504
Locations
🇹🇿

Bagamoyo Clinical Trial Facility, Bagamoyo, Tanzania

The Anti-Freaze-F Study- "Anti-TNF for Treatment of Frozen Shoulder - a Feasibility Study"

Phase 2
Completed
Conditions
Frozen Shoulder
Interventions
First Posted Date
2022-03-28
Last Posted Date
2025-01-27
Lead Sponsor
University of Oxford
Target Recruit Count
9
Registration Number
NCT05299242
Locations
🇬🇧

Grantham & District Hospital, United Lincolnshire Hospitals, Grantham, Lincolnshire, United Kingdom

🇬🇧

Conquest Hospital, Saint Leonards-on-Sea, Hastings, United Kingdom

🇬🇧

Good Hope Hospital, Sutton Coldfield, Birmingham, United Kingdom

and more 1 locations

Safety and Immunogenicity of Pvs25-IMX313/Matrix-M1 Vaccine

Early Phase 1
Terminated
Conditions
Malaria, Vivax
Interventions
Biological: Pvs25-IMX313/Matrix-M1
First Posted Date
2022-03-08
Last Posted Date
2024-08-09
Lead Sponsor
University of Oxford
Target Recruit Count
25
Registration Number
NCT05270265
Locations
🇬🇧

CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Fluid Restriction and Quality of Life on Dialysis

Not Applicable
Completed
Conditions
End Stage Renal Disease
Interventions
Behavioral: ACT Matrix
First Posted Date
2022-03-03
Last Posted Date
2022-12-08
Lead Sponsor
University of Oxford
Target Recruit Count
8
Registration Number
NCT05264220
Locations
🇬🇧

Renal and Transplant Medicine Unit (and satellite units), Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom

Oxford - Fibrates in Aortic Stenosis

Not Applicable
Conditions
Aortic Valve Stenosis
Interventions
Drug: Placental Lactogen
First Posted Date
2022-02-25
Last Posted Date
2022-02-25
Lead Sponsor
University of Oxford
Target Recruit Count
67
Registration Number
NCT05256758
Locations
🇬🇧

OUH NHS trust, Oxford, United Kingdom

PARADISE: Predicting AF After Cardiac Surgery

Active, not recruiting
Conditions
Atrial Fibrillation New Onset
Interventions
Other: Not applicable as observational study
First Posted Date
2022-02-24
Last Posted Date
2025-01-23
Lead Sponsor
University of Oxford
Target Recruit Count
13684
Registration Number
NCT05255224
Locations
🇬🇧

Critical Care Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, United Kingdom

Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults

Phase 2
Completed
Conditions
Malaria,Falciparum
Interventions
Biological: R21/Matrix-M vaccination
Drug: DHA-PIP
Drug: PQ
First Posted Date
2022-02-23
Last Posted Date
2023-10-27
Lead Sponsor
University of Oxford
Target Recruit Count
127
Registration Number
NCT05252845
Locations
🇹🇭

Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath